Hemophilia Treatment Market Size, Share, And Growth Report 2032
Hemophilia Treatment Market by Type (Hemophilia A, Hemophilia B, and Hemophilia C), by Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrates, Antifibrinolytic Agents, and Desmopressin), by Therapy (Replacement and Gene), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 16.22 Billion | USD 28.34 Billion | 6.4% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Hemophilia Treatment Market Revenue, 2016-2025 (USD Million)
- 2.2. Global Hemophilia Treatment Market: Snapshot
- Chapter 3. Hemophilia Treatment Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Hemophilia Treatment Market Drivers: Impact analysis
- 3.2.2. Increasing incidences of bleeding disorders and their rising severity
- 3.2.3. Technological Advancements
- 3.3. Market Restraints
- 3.3.1. Limited access to treatment
- 3.4. Opportunities
- 3.4.1. Advancements in gene therapy
- 3.5. Porter's Five Forces Analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Type
- 3.6.2. Market attractiveness analysis, by Product
- 3.6.3. Market attractiveness analysis, by Therapy
- 3.6.4. Market attractiveness analysis, by Region
- Chapter 4. Global Hemophilia Treatment Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Hemophilia Treatment Market: Company Market Share, 2018
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Type Launch
- 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
- 4.2.4. Research and Development and Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global Hemophilia Treatment Market - Type Analysis
- 5.1. Global Hemophilia Treatment Market: Type overview
- 5.1.1. Global Hemophilia Treatment Market revenue share, by Type, 2018 and 2025
- 5.2. Hemophilia A
- 5.2.1. Global Hemophilia Treatment Market for Hemophilia A, 2016-2025 (USD Million)
- 5.3. Hemophilia B
- 5.3.1. Global Hemophilia Treatment Market for Hemophilia B, 2016-2025 (USD Million)
- 5.4. Hemophilia C
- 5.4.1. Global Hemophilia Treatment Market for Hemophilia C, 2016-2025 (USD Million)
- 5.1. Global Hemophilia Treatment Market: Type overview
- Chapter 6. Global Hemophilia Treatment Market - Product Analysis
- 6.1. Global Hemophilia Treatment Market: Product overview
- 6.1.1. Global Hemophilia Treatment Market revenue share, by Product, 2018 and 2025
- 6.2. Recombinant Coagulation Factor Concentrates
- 6.2.1. Global Hemophilia Treatment Market for Recombinant Coagulation Factor Concentrates, 2016-2025 (USD Million)
- 6.3. Plasma Derived Coagulation Factor Concentrates
- 6.3.1. Global Hemophilia Treatment Market for Plasma Derived Coagulation Factor Concentrates, 2016-2025 (USD Million)
- 6.4. Antifibrinolytic Agents
- 6.4.1. Global Hemophilia Treatment Market for Antifibrinolytic Agents, 2016-2025 (USD Million)
- 6.5. Desmopressin
- 6.5.1. Global Hemophilia Treatment Market for Desmopressin, 2016-2025 (USD Million)
- 6.1. Global Hemophilia Treatment Market: Product overview
- Chapter 7. Global Hemophilia Treatment Market - Therapy Analysis
- 7.1. Global Hemophilia Treatment Market: Treatment overview
- 7.1.1. Global Hemophilia Treatment Market revenue share, by Treatment, 2018 and 2025
- 7.2. Replacement Therapy
- 7.2.1. Global Hemophilia Treatment Market for Replacement Therapy, 2016-2025 (USD Million)
- 7.3. Gene Therapy
- 7.3.1. Global Hemophilia Treatment Market for Gene Therapy, 2016-2025 (USD Million)
- 7.1. Global Hemophilia Treatment Market: Treatment overview
- Chapter 8. Global Hemophilia Treatment Market - Regional Analysis
- 8.1. Global Airport Logistics System: Regional overview
- 8.1.1. Global Hemophilia Treatment Market revenue share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.2.2. North America Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.2.3. North America Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.2.4.2. The U.S. Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.2.4.3. The U.S. Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.2.5. Rest of North America
- 8.2.5.1. Rest of North America Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.2.5.2. Rest of North America Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.2.5.3. Rest of North America Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.3.2. Europe Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.3.3. Europe Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.3.4. Germany
- 8.3.4.1. Germany Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.3.4.2. Germany Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.3.4.3. Germany Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.3.5. UK
- 8.3.5.1. UK Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.3.5.2. UK Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.3.5.3. UK Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.3.6. France
- 8.3.6.1. France Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.3.6.2. France Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.3.6.3. France Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.3.7.2. Rest of Europe Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.3.7.3. Rest of Europe Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.4.2. Asia Pacific Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.4.3. Asia Pacific Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.4.4. China
- 8.4.4.1. China Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.4.4.2. China Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.4.4.3. China Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.4.5. Japan
- 8.4.5.1. Japan Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.4.5.2. Japan Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.4.5.3. Japan Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.4.6. India
- 8.4.6.1. India Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.4.6.2. India Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.4.6.3. India Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.4.7.2. Rest of Asia Pacific Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.4.7.3. Rest of Asia Pacific Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.5.2. Latin America Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.5.3. Latin America Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.5.4. Brazil
- 8.5.4.1. Brazil Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.5.4.2. Brazil Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.5.4.3. Brazil Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.5.5.2. Rest of Latin America Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.5.5.3. Rest of Latin America Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Hemophilia Treatment Market Revenue, by Type, 2016-2025 (USD Million)
- 8.6.2. The Middle East and Africa Hemophilia Treatment Market Revenue, by Product, 2016-2025 (USD Million)
- 8.6.3. The Middle East and Africa Hemophilia Treatment Market Revenue, by Therapy, 2016-2025 (USD Million)
- 8.1. Global Airport Logistics System: Regional overview
- Chapter 9. Company Profile
- 9.1. Pfizer
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Type Portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Baxalta
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Type Portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Baxter International
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Type Portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. CSL Ltd.
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Type Portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Octapharma
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Type Portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. Grifols
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Type Portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. Novo Nordisk
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Type Portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Kedrion
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Type Portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. Bayer
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Type Portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Biogen Idec
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Type Portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.11. Hospira
- 9.11.1. Overview
- 9.11.2. Financials
- 9.11.3. Type Portfolio
- 9.11.4. Business strategy
- 9.11.5. Recent developments
- 9.1. Pfizer
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Hemophilia Treatment Market Revenue, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Hemophilia Treatment Market attractiveness analysis, by Type
6. Hemophilia Treatment Market attractiveness analysis, by Product
7. Hemophilia Treatment Market attractiveness analysis, by Therapy
8. Hemophilia Treatment Market attractiveness analysis, by Region
9. Company market share analysis, 2018
10. Global Hemophilia Treatment Market revenue share by Type, 2018 and 2025
11. Global Hemophilia Treatment Market Revenue for Hemophilia A, 2016–2025 (USD Million)
12. Global Hemophilia Treatment Market Revenue for Hemophilia B, 2016–2025 (USD Million)
13. Global Hemophilia Treatment Market Revenue for Hemophilia C, 2016–2025 (USD Million)
14. Global Hemophilia Treatment Market Revenue for Product, 2016–2025 (USD Million)
15. Global Hemophilia Treatment Market Revenue for Recombinant Coagulation Factor Concentrates, 2016–2025 (USD Million)
16. Global Hemophilia Treatment Market Revenue for Plasma Derived Coagulation Factor Concentrates, 2016–2025 (USD Million)
17. Global Hemophilia Treatment Market Revenue for Antifibrinolytic Agents, 2016–2025 (USD Million)
18. Global Hemophilia Treatment Market Revenue for Desmopressin, 2016–2025 (USD Million)
19. Global Hemophilia Treatment Market revenue share by Therapy, 2018 and 2025
20. Global Hemophilia Treatment Market Revenue for Replacement Therapy, 2016–2025 (USD Million)
21. Global Hemophilia Treatment Market Revenue for Gene Therapy, 2016–2025 (USD Million)
22. North America Hemophilia Treatment Market Revenue, 2016–2025 (USD Million)
23. Europe Hemophilia Treatment Market Revenue, 2016–2025 (USD Million)
24. Asia Pacific Hemophilia Treatment Market Revenue, 2016–2025 (USD Million)
25. Latin America Hemophilia Treatment Market Revenue, 2016–2025 (USD Million)
26. The Middle East and Africa Hemophilia Treatment Market Revenue, 2016–2025 (USD Million)
Table Of Tables
List of Tables
1. Hemophilia Treatment Market: Market Snapshot
2. Drivers of the Global Hemophilia Treatment Market: Impact analysis
3. Restraints of the Global Hemophilia Treatment Market: Impact analysis
4. North America Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
5. North America Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
6. North America Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
7. The U.S. Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
8. The U.S. Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
9. The U.S. Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
10. Rest of North America Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
11. Rest of North America Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
12. Rest of North America Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
13. Europe Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
14. Europe Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
15. Europe Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
16. Germany Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
17. Germany Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
18. Germany Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
19. U.K. Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
20. U.K. Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
21. U.K. Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
22. France Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
23. France Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
24. France Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
25. Rest of Europe Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
26. Rest of Europe Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
27. Rest of Europe Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
28. Asia Pacific Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
29. Asia Pacific Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
30. Asia Pacific Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
31. China Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
32. China Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
33. China Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
34. Japan Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
35. Japan Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
36. Japan Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
37. India Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
38. India Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
39. India Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
40. Rest of Asia Pacific Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
41. Rest of Asia Pacific Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
42. Rest of Asia Pacific Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
43. Latin America Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
44. Latin America Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
45. Latin America Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
46. Brazil Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
47. Brazil Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
48. Brazil Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
49. Rest of Latin America Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
50. Rest of Latin America Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
51. Rest of Latin America Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
52. The Middle East and Africa Hemophilia Treatment Market Revenue, by Type, 2016–2025 (USD Million)
53. The Middle East and Africa Hemophilia Treatment Market Revenue, by Product, 2016–2025 (USD Million)
54. The Middle East and Africa Hemophilia Treatment Market Revenue, by Therapy, 2016–2025 (USD Million)
Methodology
FrequentlyAsked Questions
Hemophilia is a genetic disorder that impairs the blood's ability to clot, leading to excessive bleeding. Treatment for hemophilia focuses on replacing the missing clotting factors, preventing bleeding episodes, and managing complications.
According to study, the Hemophilia Treatment Market size was worth around USD 16.22 billion in 2023 and is predicted to grow to around USD 28.34 billion by 2032.
The CAGR value of Hemophilia Treatment Market is expected to be around 6.4% during 2024-2032.
North America has been leading the Hemophilia Treatment Market and is anticipated to continue on the dominant position in the years to come.
The Hemophilia Treatment Market is led by players like Pfizer, Baxalta, Baxter International, CSL Ltd., Octapharma, Grifols, Novo Nordisk, Kedrion, Bayer, Biogen Idec, and Hospira.
HappyClients
